daunorubicin has been researched along with Malignant Melanoma in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (64.44) | 18.7374 |
| 1990's | 6 (13.33) | 18.2507 |
| 2000's | 5 (11.11) | 29.6817 |
| 2010's | 3 (6.67) | 24.3611 |
| 2020's | 2 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, EF; Horton, D; Weckerle, W; Winter-Mihaly, E | 1 |
| Kuhlmann, KF; Mosher, CW | 1 |
| Enyedi, G; Enyedi, KN; Lajkó, E | 1 |
| Brzózka, Z; Chudy, M; Lamch, Ł; Piechota, B; Tokarska, K; Wilk, KA; Żukowski, K | 1 |
| Cannon, RD; Gillet, JP; Gottesman, MM; Holmes, AR; Keniya, MV; Lamping, E; Niimi, M | 1 |
| Kono, M; Song, HZ; Tomita, Y | 1 |
| Dunn, IS; Haggerty, TJ; Kurnick, JT; Martin, S; Newton, EE; Riley, JL; Rose, LB | 1 |
| Asensi, M; Brown, BD; Cerdá, M; Estrela, JM; Mena, S; Obrador, E; Ortega, A; Petschen, I; Priego, S; Rodriguez, ML | 1 |
| Baggetto, LG; Barakat, S; Bernaud, J; Dayan, G; Devouassoux-Shisheboran, M; Gambrelle, J; Gayet, L; Grange, JD; Labialle, S; Rigal, D | 1 |
| Bachmann, M; Barz, S; Kniep, B; Kniep, E; Malisan, F; Ozkucur, N; Rieber, EP; Testi, R | 1 |
| Armand, JP; Bui, NB; Cappelaere, P; Chauvergne, J; Durand, M; Gary-Bobo, J; Guerrin, J | 1 |
| Crespeigne, N; Decoster, G; Kenis, Y; Klastersky, J; Rombaut, W; Rozencweig, M; Sanders, C | 1 |
| Dawson, KM | 1 |
| Averbukh, LA; Bazhanov, VS; Gol'dberg, LE; Olsuf'eva, EN; Povarov, LS | 1 |
| Thiers, BH | 1 |
| Hearst, JE; Varga, JM; Weisehahn, G | 1 |
| McNitt, S; Teague, K; Thayer, PS; Yesair, DW | 1 |
| Bhuyan, BK; Blowers, CL; Crampton, SL; Shugars, KD | 1 |
| Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M | 1 |
| Castro, DJ; Eshraghi, AA; Graeber, IP; Jongewaard, N; Paek, WH; Paiva, MB; Saxton, RE; Suh, MJ | 1 |
| Binder, AB; Bohm, LJ; Serafin, AM | 1 |
| Jordan, AM; Khan, TH; Malkin, H; Osborn, HM; Photiou, A; Riley, PA | 1 |
| Faufmann, M; MAttern, J; Volm, M; Wayss, K | 1 |
| Asato, N; Lande, S; Lerner, AB; Varga, JM | 1 |
| Chauvergne, J; Clavel, B; Klein, T; Pommatau, E | 1 |
| Benoit, P; Fontaliran, F; Gay, J; Gerbaux, A; Montely, JM | 1 |
| Chauvergne, J; Clavel, B; Klein, T; Pammatau, E | 1 |
| Goldin, A; Johnson, RK; Ovejera, AA | 1 |
| Borst, P; Roelofs, EM; Schinkel, AH | 1 |
| Glover, DJ | 1 |
| Arancia, G; Calcabrini, A; Crateri, P; Molinari, A | 1 |
| Borst, P; Lincke, CR; Schuurhuis, GJ; Smit, JJ; van der Bliek, AM; van der Velde-Koerts, T | 1 |
| Beidler, D; Dillman, RO; Johnson, DE; Ogden, J | 1 |
| Adams, EG; Bhuyan, BK; Crampton, SL; Johnson, M | 1 |
| Gundersen, S; Monfardini, S; Pinedo, H; Renard, G; Van Glabbeke, M | 1 |
| Bredehorst, R; Panneerselvam, M; Vogel, CW | 1 |
| Angelelli, B; Camaggi, CM; Comparsi, R; Pacciarini, MA; Pannuti, F; Strocchi, E | 1 |
| Di Lauro, L; Di Pietro, N; Ganzina, F; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
| Martoni, A; Pacciarini, MA; Pannuti, F; Piana, E | 1 |
| Martoni, A; Pacciarini, MA; Pannuti, F | 1 |
| Varga, JM | 1 |
| Benjamin, RS; Chawla, SP; Legha, SS | 1 |
| Karnofsky, DA; Murphy, ML; Tan, C; Tasaka, H; Yu, KP | 1 |
| Mattern, J; Volm, M; Wayss, K | 1 |
4 trial(s) available for daunorubicin and Malignant Melanoma
| Article | Year |
|---|---|
[Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone].
Topics: Adult; Aged; Clinical Trials as Topic; Dacarbazine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Middle Aged; Time Factors | 1982 |
[Chemotherapy of malignant melanoma. Results of a controlled clinical trial comparing vincristine + dacarbazin (DTIC) with and without duborimycin (author's transl)].
Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Dacarbazine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Triazenes; Vincristine | 1978 |
[Chemotherapy of disseminated malignant melanoma].
Topics: Dacarbazine; Daunorubicin; Drug Therapy, Combination; Humans; Melanoma; Remission, Spontaneous; Triazenes; Vincristine | 1978 |
The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Vomiting | 1985 |
41 other study(ies) available for daunorubicin and Malignant Melanoma
| Article | Year |
|---|---|
Synthesis and antitumor activity of sugar-ring hydroxyl analogues of daunorubicin.
Topics: Animals; Daunorubicin; In Vitro Techniques; Leukemia, Experimental; Melanoma; Mice; Neoplasms, Experimental; Structure-Activity Relationship | 1979 |
New dimeric analogues of ethidium; synthesis, interaction with DNA, and antitumor activity.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; DNA; DNA, Neoplasm; Ethidium; Leukemia L1210; Leukemia P388; Melanoma; Mice; Neoplasms, Experimental; RNA, Neoplasm | 1981 |
Three-dimensional, PEG-based hydrogels induce spheroid formation and enhance viability of A2058 melanoma cells.
Topics: Artificial Intelligence; Daunorubicin; Humans; Hydrogels; Melanoma; Spheroids, Cellular | 2023 |
Co-delivery of IR-768 and daunorubicin using mPEG-b-PLGA micelles for synergistic enhancement of combination therapy of melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Membrane Permeability; Combined Modality Therapy; Daunorubicin; Dose-Response Relationship, Drug; Drug Compounding; Drug Liberation; Humans; Melanoma; Melanoma, Cutaneous Malignant; Micelles; Nanocapsules; Photochemotherapy; Photosensitizing Agents; Polyesters; Polyethylene Glycols; Singlet Oxygen; Skin Neoplasms | 2020 |
Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clorgyline; Daunorubicin; Humans; Melanoma; Rhodamine 123; Rhodamines; Saccharomyces cerevisiae; Tacrolimus | 2014 |
Establishment of a screening system for chemicals that upregulate a melanoma antigen, Melan-A/MART-1.
Topics: Antigens, Neoplasm; Cell Line, Tumor; Cloning, Molecular; Cytochalasin D; Daunorubicin; DNA Primers; Doxorubicin; Flow Cytometry; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Immunotherapy; MART-1 Antigen; Melanoma; Neoplasm Proteins; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells.
Topics: Antigen Presentation; CD8-Positive T-Lymphocytes; Coculture Techniques; Daunorubicin; DNA Topoisomerases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunotherapy; Interferon-gamma; Interleukin-2; Jurkat Cells; Lymphocyte Activation; MART-1 Antigen; Melanoma; Receptors, Antigen, T-Cell; Transgenes | 2011 |
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Chemoradiotherapy; Cytokines; Daunorubicin; Gene Expression Regulation, Neoplastic; Gene Silencing; Glutathione; Humans; Isoxazoles; Melanoma; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Remission Induction; Survival Analysis; Xenograft Model Antitumor Assays | 2012 |
Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liver Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Metastasis; Neoplasm Proteins; Skin Neoplasms; Uveal Neoplasms; Vault Ribonucleoprotein Particles | 2005 |
9-O-acetyl GD3 protects tumor cells from apoptosis.
Topics: Acetylation; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Daunorubicin; Enzyme Inhibitors; Gangliosides; Humans; Jurkat Cells; Leukemia, T-Cell; Melanoma; Sphingosine; Time Factors | 2006 |
Phase II study of carminomycin in a human tumor cloning assay.
Topics: Breast Neoplasms; Carubicin; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Evaluation; Female; Humans; Melanoma; Ovarian Neoplasms; Tumor Stem Cell Assay | 1984 |
Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental | 1983 |
[Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
Topics: Animals; Daunorubicin; Drug Evaluation, Preclinical; Lethal Dose 50; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Male; Melanoma; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors | 1981 |
Chemotherapy of malignant melanoma.
Topics: Daunorubicin; Dicarboxylic Acids; Drug Combinations; Drug Resistance; Humans; Levodopa; Melanocyte-Stimulating Hormones; Melanoma; Methotrexate; Nitrosourea Compounds; Receptors, Estrogen; Tretinoin | 1982 |
Interactions of daunomycin and melanotropin-daunomycin with DNA.
Topics: Animals; Daunorubicin; DNA; DNA, Circular; Melanocyte-Stimulating Hormones; Melanoma; Mice; Nucleic Acid Conformation; Spectrophotometry; Structure-Activity Relationship | 1981 |
Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms; Uterine Neoplasms | 1980 |
Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo.
Topics: Animals; Cell Line; Cell Survival; Daunorubicin; Doxorubicin; Kinetics; Leukemia, Experimental; Male; Melanoma; Mice; Neoplasms, Experimental | 1980 |
Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Kinetics; Leukemia L1210; Melanoma; Mice; Neoplasms, Experimental; Nogalamycin; Ovary | 1981 |
Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP-Binding Cassette Transporters; Benzbromarone; Blotting, Northern; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Ethylmaleimide; Etoposide; Female; Fluoresceins; Humans; Male; Melanoma; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; RNA, Messenger; Tumor Cells, Cultured; Uricosuric Agents; Vinblastine | 1997 |
Improved photochemotherapy of malignant cells with daunomycin and the KTP laser.
Topics: Carcinoma, Squamous Cell; Daunorubicin; Dose-Response Relationship, Drug; Fibrosarcoma; Head and Neck Neoplasms; Humans; In Vitro Techniques; Laser Therapy; Melanoma; Palliative Care; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 1998 |
Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Count; Cell Cycle; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; G2 Phase; Humans; Melanoma; Melphalan; Mitosis; Mutation; Pentoxifylline; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Melanocyte-Directed enzyme prodrug therapy (MDEPT): development of second generation prodrugs for targeted treatment of malignant melanoma.
Topics: Agaricales; Carbamates; Daunorubicin; Drug Design; Drug Evaluation, Preclinical; Humans; Melanocytes; Melanoma; Monophenol Monooxygenase; Mustard Compounds; Nitrogen Mustard Compounds; Oxidation-Reduction; Prodrugs; Structure-Activity Relationship | 2001 |
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cricetinae; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; In Vitro Techniques; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma; Procarbazine; Rats; Rats, Inbred ACI; Sarcoma 180; Thymidine; Triaziquone; Uridine | 1975 |
Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells.
Topics: Biological Transport; Cell Division; Cells, Cultured; Chemical Phenomena; Chemistry; Daunorubicin; Melanocyte-Stimulating Hormones; Melanoma; Neoplasms, Experimental; Receptors, Cell Surface | 1977 |
[Myocardiopathy from a new anthracyclic derivative (author's transl)].
Topics: Cardiomyopathies; Daunorubicin; Heart Failure; Humans; Male; Melanoma; Middle Aged; Myocardium; Skin Neoplasms | 1979 |
Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Drug Resistance; Haplorhini; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Male; Melanoma; Mice; Neoplasm Transplantation; Transplantation, Homologous | 1976 |
Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cell Membrane; Clone Cells; Cross Reactions; Daunorubicin; DNA Probes; Drug Resistance; HeLa Cells; Humans; Melanoma; Membrane Glycoproteins; Transfection | 1991 |
New approaches to the chemotherapy of melanoma.
Topics: Alkaloids; Amifostine; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Daunorubicin; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Paclitaxel; Procarbazine; Tamoxifen; Taurine; Thiotepa; Vincristine; Vindesine | 1991 |
Effects of daunomycin on the microtubular network: a cytochemical study on a human melanoma cell line.
Topics: Cell Adhesion; Daunorubicin; Demecolcine; Dose-Response Relationship, Drug; Humans; Melanoma; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Microtubules; Tumor Cells, Cultured | 1991 |
Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Division; Cell Line; Cell Membrane; Daunorubicin; DNA; Drug Resistance; Humans; Kinetics; Melanoma; Membrane Glycoproteins; Nucleic Acid Hybridization; Phenotype; Transfection; Tumor Cells, Cultured | 1990 |
Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Line; Cytotoxicity, Immunologic; Daunorubicin; Doxorubicin; Drug Combinations; Drug Evaluation; Lymphoma; Melanoma; Methotrexate; Mice; Mice, Inbred BALB C; Mitomycin; Mitomycins; Tumor Cells, Cultured | 1989 |
Synergistic combination of menogarol and melphalan and other two drug combinations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Cells, Cultured; Daunorubicin; Doxorubicin; Drug Synergism; Melanoma; Melphalan; Menogaril; Mice; Nogalamycin | 1985 |
Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Melanoma; Menogaril; Middle Aged; Nogalamycin; Skin Neoplasms | 1987 |
Doxorubicin enhances complement susceptibility of human melanoma cells by extracellular oxygen radical formation.
Topics: Catalase; Complement System Proteins; Daunorubicin; Doxorubicin; Free Radicals; Glutathione; Glutathione Disulfide; Humans; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Immunity, Cellular; Melanoma; Superoxide Dismutase; Superoxides | 1987 |
Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study.
Topics: Administration, Oral; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Heart; Humans; Idarubicin; Kinetics; Melanoma | 1986 |
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Hematologic Diseases; Humans; Idarubicin; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Skin Neoplasms | 1986 |
A pilot study of oral idarubicin in metastatic melanoma.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Female; Humans; Idarubicin; Male; Melanoma; Middle Aged | 1986 |
Hormone-drug conjugates.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry; Daunorubicin; Kinetics; Melanocyte-Stimulating Hormones; Melanoma; Methods; Mice; Rabbits; Thyroid Gland; Thyrotropin | 1985 |
Detorubicin--an active anthracycline in untreated metastatic melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Electrocardiography; Female; Heart; Heart Diseases; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Myocardial Contraction; Skin Neoplasms; Stroke Volume; Thrombocytopenia | 1985 |
Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.
Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Daunorubicin; Evaluation Studies as Topic; Female; Humans; Lymphoma; Male; Melanoma; Middle Aged; Neuroblastoma; Rhabdomyosarcoma; Sarcoma, Ewing; Wilms Tumor | 1967 |
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cytarabine; Daunorubicin; Fluorouracil; Melanoma; Methotrexate; Mice; Neoplasm Transplantation; Plasmacytoma; Procarbazine; Rats; Thymidine; Tritium; Uridine | 1974 |